Weimin Mao
- Topics
- Esophageal Cancer Research and Treatment (9 papers)Lung Cancer Diagnosis and Treatment (6 papers)MicroRNA in disease regulation (5 papers)
- Journals
- Journal of Clinical OncologyFEBS LettersInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Weimin Mao
26 papers receiving 550 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 335
- Cancer Research 272
- Pulmonary and Respiratory Medicine 126
- Oncology 93
- Surgery 72
Countries citing papers authored by Weimin Mao
This map shows the geographic impact of Weimin Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Mao more than expected).
Fields of papers citing papers by Weimin Mao
This network shows the impact of papers produced by Weimin Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Mao. The network helps show where Weimin Mao may publish in the future.
Co-authorship network of co-authors of Weimin Mao
This figure shows the co-authorship network connecting the top 25 collaborators of Weimin Mao. A scholar is included among the top collaborators of Weimin Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weimin Mao. Weimin Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 16 | |
| 7 | 14 | |
| 8 | 9 | |
| 9 | 11 | |
| 10 | 13 | |
| 11 | 26 | |
| 12 | 7 | |
| 13 | 39 | |
| 14 | 27 | |
| 15 | [Impact of section thickness in detection of HER2 and TOP2A in breast cancer by FISH]. | 0 |
| 16 | Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection | 2 |
| 17 | 22 | |
| 18 | 3 | |
| 19 | 96 | |
| 20 | 155 |
About Weimin Mao
Weimin Mao is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Toxicology, having authored 28 papers that have together received 558 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (9 papers), Lung Cancer Diagnosis and Treatment (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (272 citations), Molecular Biology (335 citations) and Pulmonary and Respiratory Medicine (126 citations). Weimin Mao has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shu Zheng, Guofu Wang, Jingjia Ye, Yaping Xu, Xiaoling Xu, Bo Li, Xian Wang, Tian Lan, Linling Wang and Xiaojia Wang. Their work appears in journals such as Journal of Clinical Oncology, FEBS Letters and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.